ArticlePloS one2026
Metabolite profiling of saliva for the discrimination of Behcet's disease, Sjögren's syndrome, and recurrent aphthous stomatitis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral manifestations can be the initial sign of systemic diseases such as Behcet's disease (BD) and Sjogren's syndrome (PSS). Their frequency and morphology vary widely, and recurrent aphthous stomatitis (RAS) often mimics BD ulcers, complicating differentiation on clinical grounds. Nonspecific aphthoid lesions are also seen in PSS. This study aimed to identify distinctive metabolic patterns in saliva that could discriminate BD, PSS, and RAS using global metabolite profiling. Saliva samples were collected from 43 patients (BD, n = 24; PSS, n = 10; RAS, n = 9) after fasting and abstaining from oral activities for at least 90 minutes. Gas chromatography-mass spectrometry (GC/MS) was employed for metabolite profiling. Principal component analysis (PCA) and hierarchical clustering analysis (HCA) were used to distinguish groups. Variable importance in projection (VIP) scores were calculated from partial least squares discriminant analysis (PLS-DA), and ANOVA was applied to compare metabolite abundance. Forty-two metabolites were identified and categorized into amino acids, organic acids, sugars, sugar alcohols, and others. PCA and HCA demonstrated clear dis-crimination among BD, PSS, and RAS. Metabolites with VIP > 1 included malonic acid sorbitol, pyroglutamic acid, aspartic acid, decanoic acid, hexadecenoic acid, and L-proline. Notably, malonic acid and aspartic acid were significantly elevated in BD compared to PSS and RAS, suggesting their diagnostic potential. Global salivary metabolite profiling by GC/MS provides distinct metabolic signatures enabling discrimination among BD, PSS, and RAS. This approach may enhance understanding of oral mucosal manifestations in systemic autoimmune diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.